The Characteristics of COVID-19 Symptoms and Skin Manifestations among Nonhospitalized COVID-19 Patients with Psoriasis during the Omicron Pandemic in China: A Single-Center Survey-Based Study

Table 3

Multivariate logistic regression models for developing symptomatic or asymptomatic COVID-19.

Variables	Minimally adjusted OR (95% CI)^†	value	Fully adjusted OR (95% CI)^‡	value
Treatment group
BIO	References	—	References	—
NBT	0.61 (0.28–1.35)	0.210	0.58 (0.26–1.31)	0.18
TT	0.41 (0.19–0.89)	0.023	0.40 (0.18–0.90)	0.025
Gender	1.63 (0.81–3.4)	0.182	1.25 (0.56–2.81)	0.59
Age	0.98 (0.96–1.01)	0.148	0.98 (0.95–1.01)	0.17
BMI	1.00 (0.91–1.11)	0.979	1.01 (0.91–1.12)	0.86
Hypertension	—	—	1.51 (0.49–5.39)	0.50
Smoking status	—	—	0.57 (0.27–1.17)	0.13
Vaccination	—	—	1.81 (0.75–4.90)	0.21

A P value <0.05 is considered significant and marked into bold. ^†Minimally adjusted OR contains age, gender, BMI, and treatment groups. ^‡Fully adjusted OR contains age, gender, BMI, hypertension, smoking status, vaccination, and treatment groups. Abbreviations: BMI: body mass index, BIO: biologics, CI: confidence interval, NBT: nonbiological treatment, OR: odds ratio, and TT: topical treatment or without pharmacological therapy.